Is T Cell Negative Selection a Learning Algorithm?

T cell repertoires artificial immune system central tolerance learning by example negative selection self-nonself discrimination

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
11 03 2020
Historique:
received: 21 01 2020
revised: 06 03 2020
accepted: 07 03 2020
entrez: 15 3 2020
pubmed: 15 3 2020
medline: 12 3 2021
Statut: epublish

Résumé

Our immune system can destroy most cells in our body, an ability that needs to be tightly controlled. To prevent autoimmunity, the thymic medulla exposes developing T cells to normal "self" peptides and prevents any responders from entering the bloodstream. However, a substantial number of self-reactive T cells nevertheless reaches the periphery, implying that T cells do not encounter all self peptides during this negative selection process. It is unclear if T cells can still discriminate foreign peptides from self peptides they haven't encountered during negative selection. We use an "artificial immune system"-a machine learning model of the T cell repertoire-to investigate how negative selection could alter the recognition of self peptides that are absent from the thymus. Our model reveals a surprising new role for T cell cross-reactivity in this context: moderate T cell cross-reactivity should skew the post-selection repertoire towards peptides that differ systematically from self. Moreover, even some self-like foreign peptides can be distinguished provided that the peptides presented in the thymus are not too similar to each other. Thus, our model predicts that negative selection on a well-chosen subset of self peptides would generate a repertoire that tolerates even "unseen" self peptides better than foreign peptides. This effect would resemble a "generalization" process as it is found in learning systems. We discuss potential experimental approaches to test our theory.

Identifiants

pubmed: 32168897
pii: cells9030690
doi: 10.3390/cells9030690
pmc: PMC7140671
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Nat Chem Biol. 2018 Oct;14(10):934-942
pubmed: 30224695
Front Immunol. 2015 Sep 10;6:468
pubmed: 26441973
Cell. 2006 Feb 24;124(4):815-22
pubmed: 16497590
Front Immunol. 2013 Dec 26;4:485
pubmed: 24421780
Nat Rev Genet. 2010 Jan;11(1):47-59
pubmed: 19997068
Sci Data. 2018 Aug 07;5:180157
pubmed: 30084848
J Immunol. 2010 Jun 15;184(12):6731-8
pubmed: 20483723
Nat Immunol. 2001 Apr;2(4):279-81
pubmed: 11276193
Nature. 2017 Jul 6;547(7661):89-93
pubmed: 28636592
Immunity. 2010 Jan 29;32(1):29-40
pubmed: 20045355
Immunogenetics. 2009 Jan;61(1):1-13
pubmed: 19002680
Phys Rev E. 2018 Mar;97(3-1):032413
pubmed: 29776088
Nature. 1988 Aug 4;334(6181):395-402
pubmed: 3043226
Nat Commun. 2013;4:2039
pubmed: 23783831
Psychol Rev. 1995 Jul;102(3):419-457
pubmed: 7624455
Science. 1995 Feb 10;267(5199):843-8
pubmed: 17813910
Front Immunol. 2014 Feb 04;5:13
pubmed: 24550908
J Virol. 2011 May;85(10):5232-6
pubmed: 21367907
Nat Rev Immunol. 2014 Jun;14(6):377-91
pubmed: 24830344
Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1691-5
pubmed: 7680474
Cell. 1996 Feb 23;84(4):521-9
pubmed: 8598039
Nature. 2017 Jul 6;547(7661):94-98
pubmed: 28636589
Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11833-8
pubmed: 23818603
J Exp Med. 2002 Mar 4;195(5):657-64
pubmed: 11877489
PLoS One. 2008 Mar 19;3(3):e1831
pubmed: 18350167
Immunity. 2015 May 19;42(5):929-41
pubmed: 25992863
Cell. 2014 May 22;157(5):1073-87
pubmed: 24855945
J Immunol. 2012 May 1;188(9):4135-40
pubmed: 22517866
BMC Bioinformatics. 2009 May 08;10:136
pubmed: 19426475
Immunity. 2015 Nov 17;43(5):833-5
pubmed: 26588773
PLoS Comput Biol. 2012;8(3):e1002412
pubmed: 22396638
Cell Rep. 2015 May 26;11(8):1208-19
pubmed: 26004178
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16671-6
pubmed: 18946038
Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13139-44
pubmed: 25157137
Nat Commun. 2015 Jun 23;6:7484
pubmed: 26099460
Nucleic Acids Res. 2011 Jan;39(Database issue):D214-9
pubmed: 21051339
Trends Immunol. 2003 Mar;24(3):132-5
pubmed: 12615208
Nat Rev Immunol. 2012 Sep;12(9):669-77
pubmed: 22918468
Blood. 2010 May 6;115(18):3718-25
pubmed: 20200354
J Immunol. 2009 Oct 1;183(7):4337-45
pubmed: 19734234
Immunity. 2014 Aug 21;41(2):181-90
pubmed: 25148022
J Immunol. 2000 Jan 1;164(1):121-8
pubmed: 10605002
Immunity. 2015 Jan 20;42(1):95-107
pubmed: 25601203
Immunity. 2015 Nov 17;43(5):896-908
pubmed: 26572061

Auteurs

Inge M N Wortel (IMN)

Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Geert Grooteplein 26-28, 6525 GA Nijmegen, The Netherlands.

Can Keşmir (C)

Theoretical Biology, Department of Biology, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands.

Rob J de Boer (RJ)

Theoretical Biology, Department of Biology, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands.

Judith N Mandl (JN)

Department of Physiology, McGill University, 3649 Promenade Sir William Osler, Montreal, QC H3G 0B1, Canada.

Johannes Textor (J)

Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Geert Grooteplein 26-28, 6525 GA Nijmegen, The Netherlands.
Theoretical Biology, Department of Biology, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH